Koninklijke DSM N.V. (RDSMY) is a Chemicals - Specialty company in the Basic Materials sector, currently trading at $33.85. It has a SharesGrow Score of 68/100, indicating a above average investment profile with 4 out of 7 criteria passed.
Financials: revenue is $9.2B, +0.2%/yr average growth. Net income is $747M, growing at -5.1%/yr. Net profit margin is 8.1% (thin). Gross margin is 34.4% (-2.3 pp trend).
Balance sheet: total debt is $3.1B against $9.3B equity (Debt-to-Equity (D/E) ratio 0.33, conservative). Current ratio is 2.52 (strong liquidity). Debt-to-assets is 19.3%. Total assets: $16.0B.
Analyst outlook: 2 / 2 analysts rate RDSMY as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 30/100 (Fail), Past 100/100 (Pass), Health 100/100 (Pass), Moat 39/100 (Fail), Future 100/100 (Pass), Income 45/100 (Partial).